JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on February 27, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/9/7692    most recent
M311825200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loo, T. W.
Right arrow Articles by Clarke, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loo, T. W.
Right arrow Articles by Clarke, D. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print December 10, 2003
J. Biol. Chem, 10.1074/jbc.M311825200
Submitted on October 28, 2003
Revised on December 10, 2003
Accepted on December 10, 2003

Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane

Tip W. Loo, M. Claire Bartlett, and David M. Clarke

Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A8

Corresponding Author: david.clarke{at}utoronto.ca

Human P-glycoprotein (P-gp) transports a wide variety of structurally diverse compounds out of the cell. Knowledge about the packing of the transmembrane (TM) segments is essential for understanding the mechanism of drug recognition and transport. We used cysteine-scanning mutagenesis and disulfide cross-linking analysis to determine which TM segment in the COOH-half of P-gp was close to TMs 5 and 6 since these segments in the NH2-half are important for drug binding. An active Cys-less P-gp mutant cDNA was used to generate 240 double cysteine mutants that contained one cysteine in TMs 5 or 6 and another in TMs 7 or 8. The mutants were subjected to oxidative cross-linking analysis. No disulfide cross-linking was observed in the 140 TM6/TM7 or TM6/TM8 mutants. By contrast, cross-linking was detected in several P-gp TM5/TM8 mutants. At 4 oC, when thermal motion is low, P-gp mutants N296C(TM5)/G774C(TM8), I299C(TM5)/F770C(TM8), I299C(TM5)/G774C(TM8) and G300C(TM5)/F770C(TM8) showed extensive cross-linking with oxidant. These mutants retained drug-stimulated ATPase activity but their activities were inhibited after treatment with oxidant. Similarly, disulfide cross-linking was inhibited by vanadate trapping of nucleotide. These results indicate that significant conformational changes must occur between TMs 5 and 8 during ATP hydrolysis. We revised the rotational symmetry model for TM packing based on our results and by comparison to the crystal structure of MsbA (Chang, G. (2003) J. Mol. Biol. 330, 419-430) such that TM5 is adjacent to TM8, TM2 is adjacent to TM11 and TMs 1 and 7 are next to TMs 6 and 12, respectively.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System.
Physiol Rev, October 1, 2006; 86(4): 1179 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
D. Y. Haubertin, H. Madaoui, A. Sanson, R. Guerois, and S. Orlowski
Molecular Dynamics Simulations of E. coli MsbA Transmembrane Domain: Formation of a Semipore Structure
Biophys. J., October 1, 2006; 91(7): 2517 - 2531.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Tolia, L. Chavez-Gutierrez, and B. De Strooper
Contribution of Presenilin Transmembrane Domains 6 and 7 to a Water-containing Cavity in the {gamma}-Secretase Complex
J. Biol. Chem., September 15, 2006; 281(37): 27633 - 27642.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Keusekotten, R. M. Leonhardt, S. Ehses, and M. R. Knittler
Biogenesis of Functional Antigenic Peptide Transporter TAP Requires Assembly of Pre-existing TAP1 with Newly Synthesized TAP2
J. Biol. Chem., June 30, 2006; 281(26): 17545 - 17551.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
H. Omote and M. K. Al-Shawi
Interaction of Transported Drugs with the Lipid Bilayer and P-Glycoprotein through a Solvation Exchange Mechanism
Biophys. J., June 1, 2006; 90(11): 4046 - 4059.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. A. Eisenhauer, S. Shames, P. D. Pawelek, and J. W. Coulton
Siderophore Transport through Escherichia coli Outer Membrane Receptor FhuA with Disulfide-tethered Cork and Barrel Domains
J. Biol. Chem., August 26, 2005; 280(34): 30574 - 30580.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Bao, Y. Chen, S. H. Lee, S. C. Lee, L. Reuss, and G. A. Altenberg
Membrane Transport Proteins with Complete Replacement of Transmembrane Helices with Polyalanine Sequences Remain Functional
J. Biol. Chem., March 11, 2005; 280(10): 8647 - 8650.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Pleban, S. Kopp, E. Csaszar, M. Peer, T. Hrebicek, A. Rizzi, G. F. Ecker, and P. Chiba
P-Glycoprotein Substrate Binding Domains Are Located at the Transmembrane Domain/Transmembrane Domain Interfaces: A Combined Photoaffinity Labeling-Protein Homology Modeling Approach
Mol. Pharmacol., February 1, 2005; 67(2): 365 - 374.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. F. Rosenberg, R. Callaghan, S. Modok, C. F. Higgins, and R. C. Ford
Three-dimensional Structure of P-glycoprotein: THE TRANSMEMBRANE REGIONS ADOPT AN ASYMMETRIC CONFIGURATION IN THE NUCLEOTIDE-BOUND STATE
J. Biol. Chem., January 28, 2005; 280(4): 2857 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Y. Chen, M. C. Bartlett, T. W. Loo, and D. M. Clarke
The {Delta}F508 Mutation Disrupts Packing of the Transmembrane Segments of the Cystic Fibrosis Transmembrane Conductance Regulator
J. Biol. Chem., September 17, 2004; 279(38): 39620 - 39627.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. W. Loo, M. C. Bartlett, and D. M. Clarke
Processing Mutations Located throughout the Human Multidrug Resistance P-glycoprotein Disrupt Interactions between the Nucleotide Binding Domains
J. Biol. Chem., September 10, 2004; 279(37): 38395 - 38401.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Rothnie, J. Storm, J. Campbell, K. J. Linton, I. D. Kerr, and R. Callaghan
The Topography of Transmembrane Segment Six Is Altered during the Catalytic Cycle of P-glycoprotein
J. Biol. Chem., August 13, 2004; 279(33): 34913 - 34921.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. W. Loo, M. C. Bartlett, and D. M. Clarke
Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein
J. Biol. Chem., April 30, 2004; 279(18): 18232 - 18238.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.